Givaudan's organic sales growth in the third quarter came in at almost twice the level analysts had expected, as demand for luxury perfume scents accelerated. The fragrance and flavour group reported like-for-like (LFL) sales growth of 8.6% for the quarter, against analyst expectations of 4.7%.
Fragrance & Beauty drives the result
Over the first nine months, the Fragrance & Beauty division generated CHF 3.15 billion (US$3.78 billion), up 8.8% LFL and ahead of the 8% growth recorded in the same period a year earlier. It accounted for roughly 53% of the company's overall sales in that period.
In the third quarter alone, Fragrance & Beauty sales reached CHF 1.14 billion (US$1.37 billion), with LFL growth of 13.5%, up from 6.8% growth in Q3 2025. At group level, Givaudan recorded first-three-quarter sales of CHF 5.89 billion (US$7.08 billion), a report that showed a marked acceleration in sales as the nine-month period closed.
Fine fragrance and consumer products
Fine Fragrance sales rose 15.3% LFL, set against a competitive prior-year comparable of 18.7%. The back-to-back double-digit growth points to continued resilience in the business and strong demand across the premium perfume market.
Consumer Products sales increased 9.3% LFL, compared with prior-year comparable growth of 5.9%. The figures suggest that fragrance demand extends beyond fine perfumery into personal, oral, home and fabric care.
By contrast, Fragrance Ingredients and Active Beauty combined sales fell 2.5%, compared with a 1.5% LFL increase in the first nine months of 2025.
Acquisitions, currency and regions
Givaudan's LFL figures exclude acquisitions. On a reported basis, acquisitions contributed 2.8% to Fragrance & Beauty growth over the nine-month period, while currency translation had a negative impact of 3.8%; at group level, acquisitions contributed 1.4%. Two transactions highlighted by the company were the acquisitions of Belle Aire Creations for CHF 62 million (US$74.48 million) and Vollmens Fragrances for CHF 20 million (US$24 million).
Asia Pacific was the fastest-growing geography, with sales up 10.6% LFL in the first nine months of 2026, against 4.6% in the same period last year. Within Taste & Wellbeing, the region rose 7.1% LFL, compared with a 0.5% LFL decline a year earlier.
South Asia, Africa and the Middle East grew 4.1% LFL, against comparable growth of 8.8% LFL in the first nine months of 2025; Europe rose 1.5% LFL against 3.8%; and Latin America rose 1.1% LFL against 3.1%. High-growth markets advanced 7.9%, versus 2.7% in mature markets.
North America proved the most challenging region, with a 3.3% LFL sales decrease in Taste & Wellbeing, compared with 3.9% a year earlier, although the region overall grew 1.1%. Givaudan did not separate the region's financial figures by category. The company attributed the decline primarily to continued weakness in its Health and Functional business unit and to US tariff refunds made to Givaudan customers during the third quarter of 2026.
Market reaction
Following the update, Givaudan's shares rose nearly 7%, hitting a 15-month high. The results had a positive ripple effect on peers: shares in dsm-firmenich, Novonesis and Symrise rose between 1.6% and 3.1% in early trading, according to Reuters.
Vontobel analyst Arben Hasanaj said the acceleration should reinforce confidence in Givaudan's growth profile and resilience, Reuters reported. Analysts at Vontobel and Jefferies estimated Fine Fragrance sales grew about 31% organically in the third quarter alone, according to Reuters.
The company said the consistency of its growth, despite geopolitical and macroeconomic volatility, demonstrated market resilience. The figures point to continued opportunities in fine fragrances, fragrance ingredient differentiation and premiumisation.